Melanoma News and Research

Latest Melanoma News and Research

Unique immune cell linked to remission in patients with triple negative breast cancer

A unique type of immune cell has been discovered in human breast tissue, and breast cancer patients with more of these cells are more likely to survive, finds new research from the Francis Crick Institute and King's College London.

From The Francis Crick Institute 9 Oct 2019

Differences at the single-cell level can predict responses to BRAF inhibitor therapy

Patients with advanced melanoma have been able to live longer because of several newly approved targeted treatment options, including BRAF and MEK inhibitors. However, patients will often have different responses to the same treatment due to genetic variability.

8 Oct 2019

SunSmart program may have reduced skin cancer rates among younger Australians

A skin cancer prevention program called SunSmart may have contributed to a recent reduction in melanoma among younger residents of Melbourne, according to a study published October 8 in the open-access journal PLOS Medicine by Suzanne Dobbinson of Cancer Council Victoria in Australia, and colleagues.

From PLOS ONE 8 Oct 2019

Gay neighborhoods twice as likely to have indoor tanning salons, study shows

Neighborhoods with high proportions of gay and bisexual men are twice as likely to have an indoor tanning salon than neighborhoods with fewer sexual minority men, according to a study by researchers at the Stanford University School of Medicine.

4 Oct 2019

Head and neck melanoma among pediatric and young adult populations up by 51%

Head and neck melanoma among pediatric, adolescent and young adult populations in the United States and Canada increased by 51.1% from 1995 to 2014, per research from Saint Louis University.

3 Oct 2019

New anticancer molecule shows therapeutic activity in preclinical models of various cancer types

A novel anticancer molecule created by researchers at The Wistar Institute showed therapeutic activity in preclinical models of various cancer types.

3 Oct 2019

Adding local anesthetics can improve treatment for incurable breast cancer, melanoma

A new study examined the effects of local anesthetics combined with standard chemotherapy for treatment of incurable triple-negative breast cancer, as well as melanoma.

3 Oct 2019

Discovery of neoantigens could widen the possibilities for universal cancer vaccine

For more than a decade, scientist Stephen Albert Johnston and his team at Arizona State University's Biodesign Institute have pooled their energies into an often scoffed-at, high-risk, high-reward goal in medicine: to develop a universal vaccine to prevent cancer.

2 Oct 2019

Triplet therapy could benefit patients with BRAF-mutant metastatic colorectal cancer

Results presented today at the ESMO Congress 2019, Barcelona 27 September - 01 October, during the second Proffered Paper Session on Gastrointestinal tumors (colorectal) by VHIO's Director, Josep Tabernero, show that the triplet combination of the BRAF inhibitor, encorafenib, MEK inhibitor, binimetinib, and EGFR inhibitor, cetuximab, not only significantly improves overall survival but also increases objective response rates compared with standard of care in patients with BRAF V600E-mutant metastatic colorectal cancer.

30 Sep 2019

A new method to distinguish benign and cancerous skin moles

A new study has reported a cost-effective, more accurate, and less invasive way to diagnose cancerous melanoma cells in skin tumors.

30 Sep 2019

New method can help detect melanoma cells in skin tumors

Melanoma is the least common but one of the most deadly skin cancers. It accounts for only about one percent of all cases globally, but the majority of skin cancer deaths.

30 Sep 2019

Combination of two immunotherapy drugs stops or reverses progression of advanced melanoma

A combination of two immunotherapy drugs, ipilimumab and nivolumab, has stopped or reversed the progression of advanced melanoma for five years or more in one in two patients, according to a study led by The Royal Marsden NHS Foundation Trust.

28 Sep 2019

Pioneering melanoma test to be made available within two years

Scientists have developed a pioneering new test that can more accurately predict whether melanoma, a type of skin cancer, is likely to return.

27 Sep 2019

DataArt launches 'SkinCareAI' prototype app to detect early signs of melanoma

Global technology consultancy DataArt announced today the launch of “SkinCareAI” - a prototype app that analyses skin images to detect early signs of melanoma.

27 Sep 2019

Combination therapy may offer new therapeutic avenue for previously-treated NSCLC and kidney cancer patients

Pegilodecakin, a first-in-class drug currently in clinical trials, has shown positive safety results and may offer a potential new treatment avenue for patients with non-small cell lung cancer and kidney cancer.

26 Sep 2019

Investigational drug may offer new treatment option for patients with lung and kidney cancer

26 Sep 2019

Metabolic imbalance in cancer patients associated with resistance to immune checkpoint blocker

A metabolic imbalance in some cancer patients following treatment with a checkpoint inhibitor drug, nivolumab, is associated with resistance to the immunotherapy agent and shorter survival, report scientists from Dana-Farber Cancer Institute, in collaborative work with the Broad Institute of MIT and Harvard.

25 Sep 2019

Johns Hopkins researchers link a gene to melanoma growth and spread

Using a small noncoding RNA, microRNA 211, and tools that track the stability and decay of the protein-coding and noncoding RNAs in lab-grown melanoma cells, a team led by a Johns Hopkins Kimmel Cancer Center researcher identified highly unstable RNA molecules in human melanomas, including a novel miR-211 target gene DUSP3.

From Johns Hopkins Medicine 25 Sep 2019

Openspecimen chosen to manage ARTB's biospecimen library

The Auckland Region Tissue Bank is a critical component in New Zealand’s medical research infrastructure. As a central facility for storing blood and tissue samples, they have a library that could hold the secrets to unlocking cures for existing and future chronic diseases and illnesses.

25 Sep 2019

New method harnesses the power of killer T cells to attack tumor cells, treat cancer

They've been called the "special forces" of the immune system: invariant natural killer T cells. Although there are relatively few of them in the body, they are more powerful than many other immune cells.

24 Sep 2019

Melanoma News and Research

Latest Melanoma News and Research

Unique immune cell linked to remission in patients with triple negative breast cancer

Differences at the single-cell level can predict responses to BRAF inhibitor therapy

SunSmart program may have reduced skin cancer rates among younger Australians

Gay neighborhoods twice as likely to have indoor tanning salons, study shows

Head and neck melanoma among pediatric and young adult populations up by 51%

New anticancer molecule shows therapeutic activity in preclinical models of various cancer types

Adding local anesthetics can improve treatment for incurable breast cancer, melanoma

Discovery of neoantigens could widen the possibilities for universal cancer vaccine

Triplet therapy could benefit patients with BRAF-mutant metastatic colorectal cancer

A new method to distinguish benign and cancerous skin moles

New method can help detect melanoma cells in skin tumors

Combination of two immunotherapy drugs stops or reverses progression of advanced melanoma

Pioneering melanoma test to be made available within two years

DataArt launches 'SkinCareAI' prototype app to detect early signs of melanoma

Combination therapy may offer new therapeutic avenue for previously-treated NSCLC and kidney cancer patients

Investigational drug may offer new treatment option for patients with lung and kidney cancer

Metabolic imbalance in cancer patients associated with resistance to immune checkpoint blocker

Johns Hopkins researchers link a gene to melanoma growth and spread

Openspecimen chosen to manage ARTB's biospecimen library

New method harnesses the power of killer T cells to attack tumor cells, treat cancer

Pharmaceutical Manufacturing - Industry Focus eBook eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Melanoma News and Research

Latest Melanoma News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in